Security key
03843E104
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)
CUSIP: 03843E104
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 120,192,308
- Total 13F shares
- 18,511,676
- Share change
- +2,553,086
- Total reported value
- $89,959,616
- Put/Call ratio
- 87%
- Price per share
- $4.86
- Number of holders
- 56
- Value change
- +$16,355,927
- Number of buys
- 39
- Number of sells
- 18
Report period
Q2 2020
Institutions
56
Top holders
10
AQST full security history
Newer quarter: Q3 2020
Previous quarter: Q1 2020
Aquestive Therapeutics, Inc. SEC filings
Aquestive Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03843E104
Recent filing periods:
Top shareholders of AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bratton Capital Management, L.P. |
13F
|
Company |
9.6%
|
11,503,294
|
$25,192,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.52%
|
626,713
|
$1,373,000 | — | 31 Mar 2020 | |
| DG Capital Management, LLC |
13F
|
Company |
0.45%
|
546,249
|
$1,196,000 | — | 31 Mar 2020 | |
| Bracebridge Capital, LLC |
13F
|
Company |
0.36%
|
428,571
|
$1,000,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.34%
|
413,962
|
$907,000 | — | 31 Mar 2020 | |
| Eversept Partners, LP |
13F
|
Company |
0.25%
|
300,000
|
$657,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.24%
|
294,051
|
$644,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
237,394
|
$520,000 | — | 31 Mar 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.18%
|
214,222
|
$469,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.18%
|
211,462
|
$463,000 | — | 31 Mar 2020 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.15%
|
175,000
|
$383,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
149,089
|
$326,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
98,610
|
$216,000 | — | 31 Mar 2020 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.07%
|
89,429
|
$196,000 | — | 31 Mar 2020 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
0.07%
|
86,766
|
$190,000 | — | 31 Mar 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
80,500
|
$176,000 | — | 31 Mar 2020 | |
| Oak Grove Capital LLC |
13F
|
Company |
0.06%
|
70,400
|
$154,000 | — | 31 Mar 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.05%
|
58,473
|
$128,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
47,304
|
$104,000 | — | 31 Mar 2020 | |
| BANCO BILBAO VIZCAYA ARGENTARIA, S.A. |
13F
|
Company |
0.03%
|
40,512
|
$88,000 | — | 31 Mar 2020 | |
| True North Advisors, LLC |
13F
|
Company |
0.03%
|
32,295
|
$70,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
25,906
|
$57,000 | — | 31 Mar 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
21,622
|
$47,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
19,714
|
$43,000 | — | 31 Mar 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
19,400
|
$42,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
19,188
|
$42,000 | — | 31 Mar 2020 | |
| Creative Planning |
13F
|
Company |
0.01%
|
18,000
|
$39,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.01%
|
17,300
|
$38,000 | — | 31 Mar 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
16,425
|
$36,000 | — | 31 Mar 2020 | |
| Spark Investment Management LLC |
13F
|
Company |
0.01%
|
15,300
|
$33,000 | — | 31 Mar 2020 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.01%
|
13,974
|
$31,000 | — | 31 Mar 2020 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.01%
|
13,660
|
$30,000 | — | 31 Mar 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
13,360
|
$29,000 | — | 31 Mar 2020 | |
| FRONTIER INVESTMENT MGMT CO |
13F
|
Company |
0.01%
|
11,000
|
$24,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
10,622
|
$23,000 | — | 31 Mar 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
10,009
|
$19,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
8,500
|
$19,000 | — | 31 Mar 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
4,980
|
$11,000 | — | 31 Mar 2020 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
3,618
|
$8,000 | — | 31 Mar 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3,574
|
$8,000 | — | 31 Mar 2020 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
1,058
|
$2,000 | — | 31 Mar 2020 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
45
|
$99 | — | 31 Mar 2020 |
Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q2 2020
As of 30 Jun 2020,
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,511,676 shares.
The largest 10 holders included
Bratton Capital Management, L.P., PERCEPTIVE ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, Bracebridge Capital, LLC, STATE STREET CORP, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and Squarepoint Ops LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
42
Q2 2020 holders
56
Holder diff
14
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.